(Q39235934)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23194361%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

title

Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23194361%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23194361%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Elham Mohit

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23194361%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Mandana Sattari

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23194361%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Azam Bolhassani

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23194361%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Sima Rafati

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23194361%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

5

Negar Seyed

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23194361%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

6

Yasaman Taslimi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23194361%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

4

Farnaz Zahedifard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23194361%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Maryam Salehi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23194361%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

1 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23194361%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23194361%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23194361%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23194361%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

1107-1120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23194361%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Vaccination to prevent and treat cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Vaccines against human papillomavirus and cervical cancer: promises and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Clinical studies with experimental live rubella virus vaccine (strain HPV-77). Evaluation of vaccine-induced immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Induction of an antibody response in mice against human papillomavirus (HPV) type 16 after immunization with HPV recombinant Salmonella strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Combination treatment with intralesional cidofovir and viral-DNA vaccination cures large cottontail rabbit papillomavirus-induced papillomas and reduces recurrences

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

A recombinant non-pathogenic Leishmania vaccine expressing human immunodeficiency virus 1 (HIV-1) Gag elicits cell-mediated immunity in mice and decreases HIV-1 replication in human tonsillar tissue following exposure to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

The contribution of NT-gp96 as an adjuvant for increasing HPV16 E7-specific immunity in C57BL /6 mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Current status of immunological adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Loss of transgene following ex vivo gene transfer is associated with a dominant Th2 response: implications for cutaneous gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

A non-toxic lectin for antigen delivery of plant-based mucosal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Immune response to green fluorescent protein: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Bryostatin-I: a dendritic cell stimulator for chemokines induction and a promising adjuvant for a peptide based cancer vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: improving upon nature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

ISCOMATRIX adjuvant: an adjuvant suitable for use in anticancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Induction of a strong HIV-specific CD8+ T cell response in mice using a fowlpox virus vector expressing an HIV-1 multi-CTL-epitope polypeptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

What is the influence of vaccination's routes on the regression of tumors located at mucosal sites?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable route

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Why i.p. therapy cannot yet be considered as a standard of care for the first-line treatment of ovarian cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Acute effects of intraperitoneal versus subcutaneous insulin delivery on glucose homeostasis in patients with NIDDM. Veterans Affairs Implantable Insulin Pump Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Leishmania mexicanaandLeishmania major:Attenuation of Wild‐Type Parasites and Vaccination with the Attenuated Lines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.110

21 January 2018

Identifiers

DOI

10.2217/IMT.12.110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23194361%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference